Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study
暂无分享,去创建一个
R. Prentice | R. Chlebowski | M. Stefanick | J. Wactawski‐Wende | S. Beresford | M. Pettinger | F. Hubbell
[1] Lewis H Kuller,et al. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. , 2009, American journal of epidemiology.
[2] Lewis H Kuller,et al. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. , 2008, American journal of epidemiology.
[3] J. Stanford,et al. Conjugated Equine Estrogens and Colorectal Cancer Incidence and Survival: The Women's Health Initiative Randomized Clinical Trial , 2008, Cancer Epidemiology Biomarkers & Prevention.
[4] Lewis H Kuller,et al. Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. , 2008, American journal of epidemiology.
[5] Garnet L Anderson,et al. The women's health initiative: lessons learned. , 2008, Annual review of public health.
[6] J. Manson,et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. , 2008, JAMA.
[7] J. Potter,et al. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. , 2007, Cancer research.
[8] H. Cohen,et al. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board , 2007, Clinical trials.
[9] K. Barnhart,et al. Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy. , 2007, Human reproduction.
[10] C. Kooperberg,et al. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials , 2007, Clinical trials.
[11] Garnet L Anderson,et al. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. , 2006, American journal of epidemiology.
[12] Ross L Prentice,et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. , 2005, American journal of epidemiology.
[13] K. Machens,et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. , 2004, The New England journal of medicine.
[14] John Robbins,et al. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.
[15] R. Chlebowski,et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. , 2004, The New England journal of medicine.
[16] R. Langer,et al. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.
[17] C. Kooperberg,et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. , 2003, Annals of epidemiology.
[18] Ailsa E Gebbie,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333 , 2002, Journal of Family Planning and Reproductive Health Care.
[19] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[20] F. Grodstein,et al. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. , 1999, The American journal of medicine.
[21] J. Faivre,et al. Chemoprevention of colorectal cancer. , 1999, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[22] N. Hébert-croteau. A meta-analysis of hormone replacement therapy and colon cancer in women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[23] JoAnn E. Manson,et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.
[24] C. Schairer,et al. Cancer incidence and mortality in women receiving estrogen and estrogen‐progestin replacement therapy—long‐term follow‐up of a Swedish cohort , 1996, International journal of cancer.
[25] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .